These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 24724735)

  • 1. Spontaneous Dissociation of Fluocinolone Acetonide Sustained Release Implant (Retisert) with Dislocation into the Anterior Chamber.
    Chang PY; Kresch Z; Samson CM; Gentile RC
    Ocul Immunol Inflamm; 2015; 23(6):454-7. PubMed ID: 24724735
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Spontaneous dissociation and dislocation of Retisert pellet.
    Akduman L; Cetin EN; Levy J; Becker MD; Mackensen F; Lim LL
    Ocul Immunol Inflamm; 2013; 21(1):87-9. PubMed ID: 23590151
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Late spontaneous dissociation of a fluocinolone acetonide implant (Retisert).
    Rofagha S; Prechanond T; Stewart JM
    Ocul Immunol Inflamm; 2013; 21(1):77-8. PubMed ID: 23323586
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Spontaneous dislocation of a fluocinolone acetonide implant (Retisert) into the anterior chamber and its successful extraction in sympathetic ophthalmia.
    Almeida DR; Chin EK; Mears K; Russell SR; Mahajan VB
    Retin Cases Brief Rep; 2015; 9(2):142-4. PubMed ID: 25411930
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of fluocinolone acetonide sustained release implant (Retisert) dissociation during implant removal and exchange surgery.
    Nicholson BP; Singh RP; Sears JE; Lowder CY; Kaiser PK
    Am J Ophthalmol; 2012 Dec; 154(6):969-973.e1. PubMed ID: 22981365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Scleral thickness following fluocinolone acetonide implant (Retisert).
    Taban M; Lowder CY; Ventura AA; Sharma S; Nutter B; Hayden BC; Dupps WJ; Kaiser PK
    Ocul Immunol Inflamm; 2010 Aug; 18(4):305-13. PubMed ID: 20482407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcome of Multiple Implants and Dissociation of Fluocinolone Acetonide Intravitreal Implant (Retisert) in a Series of 187 Consecutive Implants.
    Freitas-Neto CA; Maghsoudlou A; Dhanireddy S; Payal A; Boonsopon S; Ratwatte MD; Foster CS
    Ocul Immunol Inflamm; 2015; 23(6):425-9. PubMed ID: 25541739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluocinolone acetonide implant (Retisert) for noninfectious posterior uveitis: thirty-four-week results of a multicenter randomized clinical study.
    Jaffe GJ; Martin D; Callanan D; Pearson PA; Levy B; Comstock T;
    Ophthalmology; 2006 Jun; 113(6):1020-7. PubMed ID: 16690128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term follow-up results of a pilot trial of a fluocinolone acetonide implant to treat posterior uveitis.
    Jaffe GJ; McCallum RM; Branchaud B; Skalak C; Butuner Z; Ashton P
    Ophthalmology; 2005 Jul; 112(7):1192-8. PubMed ID: 15921758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociations of the Fluocinolone Acetonide Implant: The Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.
    Holbrook JT; Sugar EA; Burke AE; Vitale AT; Thorne JE; Davis JL; Jabs DA;
    Am J Ophthalmol; 2016 Apr; 164():29-36. PubMed ID: 26748056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparison between the fluocinolone acetonide (Retisert) and dexamethasone (Ozurdex) intravitreal implants in uveitis.
    Arcinue CA; Cerón OM; Foster CS
    J Ocul Pharmacol Ther; 2013 Jun; 29(5):501-7. PubMed ID: 23297752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined posterior chamber intraocular lens, vitrectomy, Retisert, and pars plana tube in noninfectious uveitis.
    Ahmad ZM; Hughes BA; Abrams GW; Mahmoud TH
    Arch Ophthalmol; 2012 Jul; 130(7):908-13. PubMed ID: 22776928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of intractable posterior uveitis in pediatric patients with the fluocinolone acetonide intravitreal implant (Retisert).
    Patel CC; Mandava N; Oliver SC; Braverman R; Quiroz-Mercado H; Olson JL
    Retina; 2012 Mar; 32(3):537-42. PubMed ID: 21963487
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Spontaneous dislocation of fluocinolone acetonide implant pellets from their suture struts.
    Itty S; Callanan D; Jones R; Pecen P; Martel J; Jaffe GJ
    Am J Ophthalmol; 2015 May; 159(5):868-76.e1. PubMed ID: 25640410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. OBSERVATION: FLUOCINOLONE ACETONIDE (ILUVIEN) IMPLANT MIGRATION INTO THE ANTERIOR CHAMBER.
    Papastavrou VT; Zambarakji H; Dooley I; Eleftheriadis H; Jackson TL
    Retin Cases Brief Rep; 2017 Winter; 11(1):44-46. PubMed ID: 26909535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Migration of a Fluocinolone Acetonide Intravitreal Implant Into the Anterior Chamber.
    Li AS; Nguyen HV; Do DV
    JAMA Ophthalmol; 2020 Oct; 138(10):e201388. PubMed ID: 33030543
    [No Abstract]   [Full Text] [Related]  

  • 17. Management of fluocinolone implant dissociation during implant exchange.
    Yeh S; Cebulla CM; Witherspoon SR; Emerson GG; Emerson MV; Suhler EB; Albini TA; Flaxel CJ
    Arch Ophthalmol; 2009 Sep; 127(9):1218-21. PubMed ID: 19752436
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dexamethasone implant anterior chamber migration: risk factors, complications, and management strategies.
    Khurana RN; Appa SN; McCannel CA; Elman MJ; Wittenberg SE; Parks DJ; Ahmad S; Yeh S
    Ophthalmology; 2014 Jan; 121(1):67-71. PubMed ID: 23890421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results of fluocinolone acetonide intravitreal implant in Behçet intractable posterior uveitis.
    Oh EK; Lee EK; Yu HG
    Can J Ophthalmol; 2014 Jun; 49(3):273-8. PubMed ID: 24862774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reimplantation of a fluocinolone acetonide sustained drug delivery implant for chronic uveitis.
    Jaffe GJ
    Am J Ophthalmol; 2008 Apr; 145(4):667-675. PubMed ID: 18226800
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.